Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 24, Number 10—October 2018

Dispatch

Invasive Pneumococcal Disease in Refugee Children, Germany

Stephanie PerniciaroComments to Author , Matthias Imöhl, and Mark van der Linden
Author affiliations: University Hospital RWTH Aachen, Aachen, Germany

Main Article

Table

Invasive pneumococcal disease in refugee children and German-born children, July 1, 2014–June 30, 2017*

IPD season
 No. patients
 Mean patient age, y
 No. (%) patients
Unvaccinated
 PCV13 vaccinated
 VT serotype
 Non-VT serotype
 Resistant to >3 classes of antimicrobial drugs
Refugee children in Germany
2014–15 3 1 3 (100) 0 2 (67) 1 (33) 1 (33)
2015–16 12 3 10 (83) 2 (17) 8 (67) 4 (33) 4 (33)
2016–17 6 5 5 (83) 0 3 (50) 3 (50) 3 (50)
Total
 21
 3
 18 (86)
 2 (9)
 13 (62)
 8 (38)
 8 (38)
Germany-born children
2014–15 107 2 19 (18) 73 (68) 28 (26) 79 (74) 5 (5)
2015–16 122 2 21 (17) 86 (70) 19 (16) 103 (84) 1 (0.8)
2016–17 176 3 45 (26) 117 (66) 28 (16) 148 (84) 4 (2)
Total 405 2 85 (21) 276 (68) 75 (19) 330 (81) 10 (2)

*VT serotypes are 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 5, 7F, 3, 6A, and 19A. Antimicrobial drug resistance is determined according to the 2015 breakpoints of the Clinical and Laboratory Standards Institute (11). IPD, invasive pneumococcal disease; PCV13, 13-valent pneumococcal conjugate vaccine; VT, vaccine type.

Main Article

References
  1. Razum  OS, Saß  A-C, Bozorgmehr  K. Gesundheitliche Versorgung von Geflüchteten: Herausforderungen und Lösungsansätze. Bundesgesundheitsblatt. 2016;59:543–4. DOIGoogle Scholar
  2. Wenner  J, Razum  O, Schenk  L, Ellert  U, Bozorgmehr  K. Gesundheit von Kindern und Jugendlichen aus Familien mit ungesichertem Aufenthaltsstatus im Vergleich zu Kindern mit und ohne Migrationshintergrund: Auswertung der KiGGS-Daten 2003–06. Bundesgesundheitsblatt. 2016;59:627–35. DOIGoogle Scholar
  3. O’Brien  KL, Wolfson  LJ, Watt  JP, Henkle  E, Deloria-Knoll  M, McCall  N, et al.; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. DOIPubMedGoogle Scholar
  4. Nnadi  C, Etsano  A, Uba  B, Ohuabunwo  C, Melton  M, Wa Nganda  G, et al. Approaches to vaccination among populations in areas of conflict. J Infect Dis. 2017;216(suppl_1):S368–72. DOIPubMedGoogle Scholar
  5. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2017 global summary [cited 2017 Sept 20]. http://apps.who.int/immunization_monitoring/globalsummary/schedules
  6. Grote  U, Schleenvoigt  BT, Happle  C, Dopfer  C, Wetzke  M, Ahrenstorf  G, et al. Norovirus outbreaks in german refugee camps in 2015. Z Gastroenterol. 2017;55:997–1003. DOIPubMedGoogle Scholar
  7. Kühne  AG, Gilsdorf  A. Ausbrüche von Infektionskrankheiten in Gemeinschaftsunterkünften für Asylsuchende 2004–2014 in Deutschland. Bundesgesundheitsblatt. 2016;59:570–7. DOIGoogle Scholar
  8. Robert Koch Institut. Konzept zur Umsetzung frühzeitiger Impfungen bei Asylsuchenden nach Ankunft in Deutschland. Epidemiologisches Bulletin. 2015;41:439–48.
  9. van der Linden  M, Falkenhorst  G, Perniciaro  S, Fitzner  C, Imöhl  M. Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany. PLoS One. 2016;11:e0161257. DOIPubMedGoogle Scholar
  10. Imöhl  M, Reinert  RR, van der Linden  M. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany. Int J Med Microbiol. 2015;305:776–83. DOIPubMedGoogle Scholar
  11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement (M100-S25). Wayne (PA): The Institute; 2015.
  12. Heinze  G. A comparative investigation of methods for logistic regression with separated or nearly separated data. Stat Med. 2006;25:4216–26. DOIPubMedGoogle Scholar
  13. Pavlopoulou  IDT, Tanaka  M, Dikalioti  S, Samoli  E, Nisianakis  P, Boleti  OD, et al. Clinical and laboratory evaluation of new immigrant and refugee children arriving in Greece. BMC Pediatr. 2017;17:132. DOIPubMedGoogle Scholar
  14. Hampton  LM, Farley  MM, Schaffner  W, Thomas  A, Reingold  A, Harrison  LH, et al. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis. 2012;205:401–11. DOIPubMedGoogle Scholar
  15. Grijalva  CG. Decrease in antibiotic use, an added benefit of PCVs. Lancet Infect Dis. 2014;14:175–7. DOIPubMedGoogle Scholar

Main Article

Page created: September 16, 2018
Page updated: September 16, 2018
Page reviewed: September 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external